Skip to content

Additive Effect of Intravenous Acetaminophen on Postoperative Pain Control

Additive Effect of Intravenous Acetaminophen Administered at the End of Surgery on Postoperative Pain Control With Nefopam and Fentanyl-based Patient-controlled Analgesia: A Double-blind Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03644147
Enrollment
84
Registered
2018-08-23
Start date
2018-08-27
Completion date
2021-01-07
Last updated
2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Disease, Postoperative Pain

Brief summary

This study aimed to evaluate the additive effect of acetaminophen on postoperative pain control in patients receiving nefopam and fentanyl-based patient-controlled analgesia. Participants undergoing laparoscopic hysterectomy will be randomly assigned to treatment group or control group. After end of surgery, acetaminophen or normal saline (placebo) will be administered intravenously depending on the group assigned.

Interventions

DRUGAcetaminophen

Acetaminophen will be intravenously administrated to treatment group after the end of surgery.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Double-blind randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing total laparoscopic hysterectomy due to uterine myoma, cervical cancer, endometriosis, uterine prolapse

Exclusion criteria

* Liver disease (aspartate transaminase OR alanine transaminase \> 80 IU/L) * Chronic kidney disease (GFR \< 30 ml/min/1.73m2) * History of drug allergy * Chronic pain lasting more than 3 months * Conversion to laparotomy * Complex surgery (co-operation with colon surgeon or urologist) * Limitation in expressing pain

Design outcomes

Primary

MeasureTime frameDescription
Total volume of administered analgesics during postoperative 24 hours24 hoursmorphine equivalent dose of patient-controlled analgesics administered during first 24 hours after end of surgery

Secondary

MeasureTime frameDescription
Patient satisfaction score24 hours11-point numeric rating scale ranging from '0' representing one extreme (e.g. extremely dissatisfied) to '10' representing the other extreme (e.g. extremely satisfied)
Postoperative nausea and vomiting24 hours4-scales scoring (none; mild; moderate; severe)
Pain score24 hours11-point numeric rating scale ranging from '0' representing one pain extreme (e.g. no pain) to '10' representing the other pain extreme (e.g. pain as bad as you can imagine or worst pain imaginable)
Use of alternative analgesics24 hoursAdditional administration of other analgesics
Length of stayFrom date of hospital admission until the date of discharge, an average of 1 weekHospital length of stay
Opioid-related adverse effect24 hoursIncidence of respiratory, gastrointestinal, and central nervous system complications

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026